Meeting
2023 ASCO Genitourinary Cancers Symposium
“It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance.
Authors
Ryan Sutherland
Yale School of Medicine, New Haven, CT
Ryan Sutherland , Cary Philip Gross , Xiaomei Ma , Farah Jeong , Tyler M Seibert , Matthew R. Cooperberg , William Catalona , Stacy Loeb , Dena Schulman-Green , Michael Leapman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 334)
DOI
10.1200/JCO.2023.41.6_suppl.334
Abstract #
334
Poster Bd #
L12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Distribution of NCCN risk classifications using MRI-ultrasound fusion versus systematic 12 core biopsies.
First Author: Ghazal Khajir
Poster
2020 Genitourinary Cancers Symposium
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).
First Author: Anna Lantz
Poster
2019 Genitourinary Cancers Symposium
Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Avinash Maganty
Poster
2019 Genitourinary Cancers Symposium
Cost implications of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Michelle Yu